126 related articles for article (PubMed ID: 26000396)
1. Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis.
Shukla P; Mathur V; Kumar A; Khedgikar V; Teja VB; Chaudhary D; Kushwaha P; Bora HK; Konwar R; Trivedi R; Mishra PR
J Biomed Nanotechnol; 2014 Nov; 10(11):3381-91. PubMed ID: 26000396
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Ramachandran C; Nair SM; Escalon E; Melnick SJ
J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718
[TBL] [Abstract][Full Text] [Related]
5. Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways.
Saleh EM; El-awady RA; Eissa NA; Abdel-Rahman WM
Cancer Biol Ther; 2012 Sep; 13(11):1058-71. PubMed ID: 22895066
[TBL] [Abstract][Full Text] [Related]
6. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
7. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
[TBL] [Abstract][Full Text] [Related]
8. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
9. Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model.
Zhang W; Cui T; Liu L; Wu Q; Sun L; Li L; Wang N; Gong C
J Biomed Nanotechnol; 2015 Jul; 11(7):1173-82. PubMed ID: 26307840
[TBL] [Abstract][Full Text] [Related]
10. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.
Ganta S; Devalapally H; Amiji M
J Pharm Sci; 2010 Nov; 99(11):4630-41. PubMed ID: 20845461
[TBL] [Abstract][Full Text] [Related]
11. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
Chen Y; Deng Y; Zhu C; Xiang C
Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
[TBL] [Abstract][Full Text] [Related]
12. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
Kretzer IF; Maria DA; Maranhão RC
Cell Oncol (Dordr); 2012 Dec; 35(6):451-60. PubMed ID: 23055341
[TBL] [Abstract][Full Text] [Related]
13. Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis.
Shukla P; Dwivedi P; Gupta PK; Mishra PR
Expert Opin Drug Deliv; 2014 Nov; 11(11):1697-712. PubMed ID: 25046368
[TBL] [Abstract][Full Text] [Related]
14. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.
Al-Rabia MW; Alhakamy NA; Rizg WY; Alghaith AF; Ahmed OAA; Fahmy UA
Drug Deliv; 2022 Dec; 29(1):807-820. PubMed ID: 35266425
[TBL] [Abstract][Full Text] [Related]
15. Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells.
Schultze E; Coradini K; Dos Santos Chaves P; da Silva LP; Buss J; Guterres SS; Collares T; Beck RCR; Pohlmann AR; Seixas FK
Pharmacol Rep; 2017 Dec; 69(6):1408-1412. PubMed ID: 29154195
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal Delivery of Polyphenon 60 and Curcumin Nanoemulsion Gel.
Kaur A; Saxena Y; Bansal R; Gupta S; Tyagi A; Sharma RK; Ali J; Panda AK; Gabrani R; Dang S
AAPS PharmSciTech; 2017 Aug; 18(6):2188-2202. PubMed ID: 28070848
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Zhang S; Lu C; Zhang X; Li J; Jiang H
Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
[TBL] [Abstract][Full Text] [Related]
20. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.
Jha SK; Han HS; Subedi L; Pangeni R; Chung JY; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
Drug Deliv; 2020 Dec; 27(1):1501-1513. PubMed ID: 33107339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
